VEA
SGYP

Virtus ETF Advisers’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

Virtus ETF Advisers’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-254,541
Closed -$433K – 420
2018
Q3 		$433K Sell
254,541
-186,920
-42% -$335K 0.05% 149
2018
Q2 		$768K Buy
+441,461
New +$763K 0.68% 54
2017
Q4 		– Sell
-247,030
Closed -$716K – 296
2017
Q3 		$716K Hold
247,030
– – 0.1% 71
2017
Q2 		$1.1M Buy
247,030
+185,922
+304% +$767K 0.16% 51
2017
Q1 		$285K Buy
61,108
+5,858
+11% +$34K 0.05% 143
2016
Q4 		$336K Sell
55,250
-13,004
-19% -$68K 0.1% 105
2016
Q3 		$376K Hold
68,254
– – 0.18% 83
2016
Q2 		$259K Buy
68,254
+24,913
+57% +$84.4K 0.19% 82
2016
Q1 		$120K Sell
43,341
-2,702
-6% -$9.79K 0.17% 139
2015
Q4 		$261K Buy
+46,043
New +$281K 0.82% 60

Other funds holding SGYP

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
JG
Jefferies Group New York $3.42B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return
OCM
Opti Capital Management New York $1.39B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citigroup
Citigroup New York $157B AUM 32.99% 1-Year Est. Return